Home » Newsletters » BioWorld Science

BioWorld Science

Nov. 12, 2014

View Archived Issues

Clearance of hepatic sphingomyelin in patients with Niemann-Pick disease type B treated with rhASM

HMOX1 genetic variations associated with severe malarial anemia

Presidio enters into two agreements for HCV NS5A inhibitor PPI-668

Boehringer Ingelheim plans phase II trial of BI-409306 in patients with schizophrenia

Novavax begins phase I trial of RSV F Vaccine in pediatric subjects

Janssen to begin phase I study of JNJ-49122944

OncoSec Medical receives grant to identify biomarkers for response to IL-12 gene therapy

Promising topline data from phase II study of tivantinib in metastatic prostate cancer

GE Healthcare and Takeda form liver fibrosis imaging collaboration

Ono Pharmaceutical reviews milestones of second quarter of fiscal 2014

Bionomics plans further clinical development of BNC-210

Results presented for a number of biomarkers of inflammatory bowel disease

Phase I results demonstrate the potential of LUM-002 in treatment of NASH

EnGeneIC initiates phase I trial of miR-16 in MPM

PBI-4050 cleared to commence trials in patients with diabetic kidney disease

AVEO Oncology enters into agreement with Ophthotech for tivozanib

Merck & Co. patents detail novel orexin antagonists

Threshold Pharmaceuticals receives FDA fast track designation for TH-302

Kissei Pharmaceutical reports development of D2 receptor agonists

iBio licenses technology to Caliber for production of Ebola virus antibodies

Japan researchers prepare and test novel anti-HB-EGF MAbs

Daiichi Sankyo patents new phosphate transporter inhibitors

Kaketsuken launches Byclot combination for intravenous injection in Japan

Czech organizations report tamoxifen derivatives

Brodalumab superior to ustekinumab in phase III trial in moderate to severe plaque psoriasis

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...